Theraplix
Jump to navigation
Jump to search
Theraplix is a European pharmaceutical company. Founded in 1931[1] by the pharmacist François Albert-Buisson,[2][3] It is now a subsidiary of Sanofi.[4]
One of their products is the antipsychotic cyamemazine (Tercian).
Their products include: Amidezel, Diamex, Hexomedine Solution, Cathomycine, Kanamylone, Theraleneand Trecator. In the 1960s, they distributed gifts to physicians in the form of collage cards. They were mostly of Asian subjects and were suitable for framing.[citation needed]
References
- ^ "Organization | Theraplix".
- ^ "Theraplix [Etablissements Albert Buisson] | Mads".
- ^ "François ALBERT-BUISSON | Académie française".
- ^ "Company Overview of Theraplix S.A.S." Bloomberg. 29 October 2018. Retrieved 29 October 2018.
| International | |
|---|---|
| National | |
| Other | |
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with short description
- Short description matches Wikidata
- All articles with unsourced statements
- Articles with unsourced statements from August 2022
- Articles with VIAF identifiers
- Articles with BNF identifiers
- Articles with BNFdata identifiers
- Articles with SUDOC identifiers
- Pharmaceutical companies of France
- Companies based in Paris
- Sanofi
- All stub articles
- Pharmacology stubs